Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes
Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clin...
Gespeichert in:
| Veröffentlicht in: | American journal of infection control 2014-02, Vol.42 (2), p.206-208 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 208 |
|---|---|
| container_issue | 2 |
| container_start_page | 206 |
| container_title | American journal of infection control |
| container_volume | 42 |
| creator | Özgür, Eylem Sercan, MD Horasan, Elif Sahin, MD Karaca, Kerem, MD Ersöz, Gülden, MD Naycı Atış, Sibel, MD Kaya, Ali, MD |
| description | Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays. |
| doi_str_mv | 10.1016/j.ajic.2013.09.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1494315127</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0196655313012145</els_id><sourcerecordid>3223843221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-a69cee95f3f106d249a6fe05ee90577777ea70a21de7121794b33b50a938d3d73</originalsourceid><addsrcrecordid>eNp9kttq3DAQhk1paTZpX6AXRVAKuYi3Olj2qpRCCD1BoNDTrRhL46KNLW0lOTRP0NeuzG4ayEV1Ixi-f5j5_6mqZ4yuGWXtq-0ats6sOWViTdWaUvGgWjHJu1pw1T6sVpSptm6lFEfVcUpbSqkSrXxcHfGm2UjRbVbVnx_osxshh1hDSsE4yGjJzuM8Be-A2BlJDgR_Z_TJXSOxcf5ZR0wuZfCZnBvnMYceTMZIepgn8N458pp8cemKDKUeYjojZnTeGRjJgJDnoj8j4C0JczZhwvSkejTAmPDp4T-pvr9_9-3iY335-cOni_PL2jStyjW0yiAqOYiB0dbyRkE7IJWlRmW3PISOAmcWO8ZZp5peiF5SUGJjhe3ESXW677uL4deMKevJJYPjCB7DnDRrVCOYZHxBX9xDt2GOvkynmSxm00aqheJ7ysSQUsRB76KbIN5oRvUSk97qJSa9xKSp0kVZRM8Pred-QvtPcptLAV4eAEjFtCGCNy7dcRsuSxtZuDd7Dotn1w6jTsahN2hdRJO1De7_c7y9J7-N6QpvMN3tqxPXVH9dDmq5JyZocbeR4i9mK8Z5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1500304597</pqid></control><display><type>article</type><title>Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Özgür, Eylem Sercan, MD ; Horasan, Elif Sahin, MD ; Karaca, Kerem, MD ; Ersöz, Gülden, MD ; Naycı Atış, Sibel, MD ; Kaya, Ali, MD</creator><creatorcontrib>Özgür, Eylem Sercan, MD ; Horasan, Elif Sahin, MD ; Karaca, Kerem, MD ; Ersöz, Gülden, MD ; Naycı Atış, Sibel, MD ; Kaya, Ali, MD</creatorcontrib><description>Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays.</description><identifier>ISSN: 0196-6553</identifier><identifier>EISSN: 1527-3296</identifier><identifier>DOI: 10.1016/j.ajic.2013.09.003</identifier><identifier>PMID: 24485378</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acinetobacter baumannii ; Acinetobacter baumannii - drug effects ; Acinetobacter baumannii - isolation & purification ; Acinetobacter Infections - epidemiology ; Acinetobacter Infections - microbiology ; Acinetobacter Infections - mortality ; Acinetobacter Infections - pathology ; Adult ; Aged ; Bacteria ; Biological and medical sciences ; Cohort Studies ; Comparative analysis ; Drug resistance ; Drug Resistance, Multiple, Bacterial ; Epidemiology. Vaccinations ; Female ; General aspects ; Human infectious diseases. Experimental studies and models ; Humans ; Infection Control ; Infectious Disease ; Infectious diseases ; Length of Stay ; Male ; Medical sciences ; Middle Aged ; Mortality ; Outcome ; Pneumology ; Pneumonia ; Pneumonia, Ventilator-Associated - epidemiology ; Pneumonia, Ventilator-Associated - microbiology ; Pneumonia, Ventilator-Associated - mortality ; Pneumonia, Ventilator-Associated - pathology ; Respiratory system : syndromes and miscellaneous diseases ; Retrospective Studies ; Risk Factors ; SAPS II ; Simplified Acute Physiology Score II ; Survival Analysis ; Treatment Outcome ; Ventilator-associated pneumonia</subject><ispartof>American journal of infection control, 2014-02, Vol.42 (2), p.206-208</ispartof><rights>Association for Professionals in Infection Control and Epidemiology, Inc.</rights><rights>2014 Association for Professionals in Infection Control and Epidemiology, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.</rights><rights>Copyright Mosby-Year Book, Inc. Feb 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-a69cee95f3f106d249a6fe05ee90577777ea70a21de7121794b33b50a938d3d73</citedby><cites>FETCH-LOGICAL-c469t-a69cee95f3f106d249a6fe05ee90577777ea70a21de7121794b33b50a938d3d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajic.2013.09.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28250335$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24485378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özgür, Eylem Sercan, MD</creatorcontrib><creatorcontrib>Horasan, Elif Sahin, MD</creatorcontrib><creatorcontrib>Karaca, Kerem, MD</creatorcontrib><creatorcontrib>Ersöz, Gülden, MD</creatorcontrib><creatorcontrib>Naycı Atış, Sibel, MD</creatorcontrib><creatorcontrib>Kaya, Ali, MD</creatorcontrib><title>Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes</title><title>American journal of infection control</title><addtitle>Am J Infect Control</addtitle><description>Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays.</description><subject>Acinetobacter baumannii</subject><subject>Acinetobacter baumannii - drug effects</subject><subject>Acinetobacter baumannii - isolation & purification</subject><subject>Acinetobacter Infections - epidemiology</subject><subject>Acinetobacter Infections - microbiology</subject><subject>Acinetobacter Infections - mortality</subject><subject>Acinetobacter Infections - pathology</subject><subject>Adult</subject><subject>Aged</subject><subject>Bacteria</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Comparative analysis</subject><subject>Drug resistance</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Epidemiology. Vaccinations</subject><subject>Female</subject><subject>General aspects</subject><subject>Human infectious diseases. Experimental studies and models</subject><subject>Humans</subject><subject>Infection Control</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Outcome</subject><subject>Pneumology</subject><subject>Pneumonia</subject><subject>Pneumonia, Ventilator-Associated - epidemiology</subject><subject>Pneumonia, Ventilator-Associated - microbiology</subject><subject>Pneumonia, Ventilator-Associated - mortality</subject><subject>Pneumonia, Ventilator-Associated - pathology</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>SAPS II</subject><subject>Simplified Acute Physiology Score II</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>Ventilator-associated pneumonia</subject><issn>0196-6553</issn><issn>1527-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kttq3DAQhk1paTZpX6AXRVAKuYi3Olj2qpRCCD1BoNDTrRhL46KNLW0lOTRP0NeuzG4ayEV1Ixi-f5j5_6mqZ4yuGWXtq-0ats6sOWViTdWaUvGgWjHJu1pw1T6sVpSptm6lFEfVcUpbSqkSrXxcHfGm2UjRbVbVnx_osxshh1hDSsE4yGjJzuM8Be-A2BlJDgR_Z_TJXSOxcf5ZR0wuZfCZnBvnMYceTMZIepgn8N458pp8cemKDKUeYjojZnTeGRjJgJDnoj8j4C0JczZhwvSkejTAmPDp4T-pvr9_9-3iY335-cOni_PL2jStyjW0yiAqOYiB0dbyRkE7IJWlRmW3PISOAmcWO8ZZp5peiF5SUGJjhe3ESXW677uL4deMKevJJYPjCB7DnDRrVCOYZHxBX9xDt2GOvkynmSxm00aqheJ7ysSQUsRB76KbIN5oRvUSk97qJSa9xKSp0kVZRM8Pred-QvtPcptLAV4eAEjFtCGCNy7dcRsuSxtZuDd7Dotn1w6jTsahN2hdRJO1De7_c7y9J7-N6QpvMN3tqxPXVH9dDmq5JyZocbeR4i9mK8Z5</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Özgür, Eylem Sercan, MD</creator><creator>Horasan, Elif Sahin, MD</creator><creator>Karaca, Kerem, MD</creator><creator>Ersöz, Gülden, MD</creator><creator>Naycı Atış, Sibel, MD</creator><creator>Kaya, Ali, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Mosby-Year Book, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140201</creationdate><title>Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes</title><author>Özgür, Eylem Sercan, MD ; Horasan, Elif Sahin, MD ; Karaca, Kerem, MD ; Ersöz, Gülden, MD ; Naycı Atış, Sibel, MD ; Kaya, Ali, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-a69cee95f3f106d249a6fe05ee90577777ea70a21de7121794b33b50a938d3d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acinetobacter baumannii</topic><topic>Acinetobacter baumannii - drug effects</topic><topic>Acinetobacter baumannii - isolation & purification</topic><topic>Acinetobacter Infections - epidemiology</topic><topic>Acinetobacter Infections - microbiology</topic><topic>Acinetobacter Infections - mortality</topic><topic>Acinetobacter Infections - pathology</topic><topic>Adult</topic><topic>Aged</topic><topic>Bacteria</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Comparative analysis</topic><topic>Drug resistance</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Epidemiology. Vaccinations</topic><topic>Female</topic><topic>General aspects</topic><topic>Human infectious diseases. Experimental studies and models</topic><topic>Humans</topic><topic>Infection Control</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Outcome</topic><topic>Pneumology</topic><topic>Pneumonia</topic><topic>Pneumonia, Ventilator-Associated - epidemiology</topic><topic>Pneumonia, Ventilator-Associated - microbiology</topic><topic>Pneumonia, Ventilator-Associated - mortality</topic><topic>Pneumonia, Ventilator-Associated - pathology</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>SAPS II</topic><topic>Simplified Acute Physiology Score II</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>Ventilator-associated pneumonia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özgür, Eylem Sercan, MD</creatorcontrib><creatorcontrib>Horasan, Elif Sahin, MD</creatorcontrib><creatorcontrib>Karaca, Kerem, MD</creatorcontrib><creatorcontrib>Ersöz, Gülden, MD</creatorcontrib><creatorcontrib>Naycı Atış, Sibel, MD</creatorcontrib><creatorcontrib>Kaya, Ali, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of infection control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özgür, Eylem Sercan, MD</au><au>Horasan, Elif Sahin, MD</au><au>Karaca, Kerem, MD</au><au>Ersöz, Gülden, MD</au><au>Naycı Atış, Sibel, MD</au><au>Kaya, Ali, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes</atitle><jtitle>American journal of infection control</jtitle><addtitle>Am J Infect Control</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>42</volume><issue>2</issue><spage>206</spage><epage>208</epage><pages>206-208</pages><issn>0196-6553</issn><eissn>1527-3296</eissn><abstract>Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>24485378</pmid><doi>10.1016/j.ajic.2013.09.003</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0196-6553 |
| ispartof | American journal of infection control, 2014-02, Vol.42 (2), p.206-208 |
| issn | 0196-6553 1527-3296 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1494315127 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Acinetobacter baumannii Acinetobacter baumannii - drug effects Acinetobacter baumannii - isolation & purification Acinetobacter Infections - epidemiology Acinetobacter Infections - microbiology Acinetobacter Infections - mortality Acinetobacter Infections - pathology Adult Aged Bacteria Biological and medical sciences Cohort Studies Comparative analysis Drug resistance Drug Resistance, Multiple, Bacterial Epidemiology. Vaccinations Female General aspects Human infectious diseases. Experimental studies and models Humans Infection Control Infectious Disease Infectious diseases Length of Stay Male Medical sciences Middle Aged Mortality Outcome Pneumology Pneumonia Pneumonia, Ventilator-Associated - epidemiology Pneumonia, Ventilator-Associated - microbiology Pneumonia, Ventilator-Associated - mortality Pneumonia, Ventilator-Associated - pathology Respiratory system : syndromes and miscellaneous diseases Retrospective Studies Risk Factors SAPS II Simplified Acute Physiology Score II Survival Analysis Treatment Outcome Ventilator-associated pneumonia |
| title | Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii : Risk factors, clinical features, and outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A42%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ventilator-associated%20pneumonia%20due%20to%20extensive%20drug-resistant%20Acinetobacter%20baumannii%20:%20Risk%20factors,%20clinical%20features,%20and%20outcomes&rft.jtitle=American%20journal%20of%20infection%20control&rft.au=%C3%96zg%C3%BCr,%20Eylem%20Sercan,%20MD&rft.date=2014-02-01&rft.volume=42&rft.issue=2&rft.spage=206&rft.epage=208&rft.pages=206-208&rft.issn=0196-6553&rft.eissn=1527-3296&rft_id=info:doi/10.1016/j.ajic.2013.09.003&rft_dat=%3Cproquest_cross%3E3223843221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1500304597&rft_id=info:pmid/24485378&rft_els_id=1_s2_0_S0196655313012145&rfr_iscdi=true |